Xeljanz XR 11 MG tablet UU 30S

Ended Awarded

Contract number
SPE2DR26FH1BG
Awardee
Awarding agency
Obligated
$6,794

Award facts

Contract value 100% obligated
$6,794.30 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $6,794.30 delivery order to AmerisourceBergen Drug Corp on July 13, 2026, for XELJANZ XR 11 mg tablets (30-count unit of use packaging), with final delivery due July 14, 2026.

Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier to the Department of Defense and federal healthcare systems.

Quick answers

Who was awarded contract SPE2DR26FH1BG?

SPE2DR26FH1BG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 13, 2026.

How much is contract SPE2DR26FH1BG worth?

The government has obligated $6,794 on SPE2DR26FH1BG.

Is contract SPE2DR26FH1BG an order under another contract?

Yes. SPE2DR26FH1BG is a delivery order under SPE2DR25D3016, an indefinite delivery contract.

Was contract SPE2DR26FH1BG competed?

The extent of competition for SPE2DR26FH1BG was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award